Investor Relations
  Chemotaxis Chemorepulsion Chemoattraction
Figure 3: The technology developed by Celtaxsys is presently being applied to four therapeutic areas, each of which can be viewed from a perspective of defective immune cell migration. The therapeutic resolution of these diseases is achieved by introduction or removal of a cell migration agent, as indicated.
Home
Technology
Management
Investors
Careers
Contact
Privacy Policy
Terms of Use
Copyright © 2008 Celtaxsys. All rights reserved.